Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1–9) axis in experimental hypertension

Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro

(2010) Maria Paz Ocaranza et al.   JOURNAL OF HYPERTENSION

Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients

(2009) E. Büssemaker et al.   ATHEROSCLEROSIS

Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

(2008) Julie R Ingelfinger   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases

(2008) Clark A. Sehon et al.   JOURNAL OF MEDICINAL CHEMISTRY

Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions

(2008) JC Sluimer et al.   JOURNAL OF PATHOLOGY

Acute Inhibition of Rho-Kinase Attenuates Pulmonary Hypertension in Patients with Congenital Heart Disease

(2008) Fuhai Li et al.   PEDIATRIC CARDIOLOGY